Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
James Shepherd(University of Glasgow), Gerard J. Blauw(Leiden University), Michael Murphy(Cork University Hospital), Edward Bollen(Leiden University Medical Center), Brendan M. Buckley(Cork University Hospital), Stuart M. Cobbe(University of Glasgow), Ian Ford(University of Glasgow), Allan Gaw, Michael E. Hyland(Cork University Hospital), J. Wouter Jukema(Leiden University Medical Center), Adriaan M. Kamper(Leiden University), Peter W. Macfarlane(University of Glasgow), A. Edo Meinders(Leiden University Medical Center), John Norrie(University of Glasgow), Chris J. Packard, Ivan J. Perry(Cork University Hospital), David J. Stott(University of Glasgow), Brian Sweeney(Cork University Hospital), Gillian Twomey(University College Cork), Rudi GJ Westendorp(Leiden University)
Cited by 3,394
Abstract
Related Papers
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group|New England Journal of Medicine|1998|5.3k